Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: J Mol Cell Cardiol. 2015 Oct 20;89(Pt B):268–279. doi: 10.1016/j.yjmcc.2015.10.022

Fig. 2.

Fig. 2

The effect of cardiac fibroblast-derived exosomes on cardiomyocyte hypertrophy. Neonatal rat cardiomyocytes were treated with neonatal rat cardiac fibroblasts-derived exosomes (Exo) or angiotensin II (Ang II) as indicated for 48 h and then subjected to (A) cell surface area measurement, (B) [3H]-Leucine uptake, (C and D) qPCR analysis of gene expression. n=4, *p<0.05 vs. vehicle treated control (−).